Amicus Therapeutics Inc (FOLD.OQ)
FOLD.OQ on NASDAQ Stock Exchange Global Market
2.49USD
4:00pm EDT
2.49USD
4:00pm EDT
Price Change (% chg)
$0.05 (+2.05%)
$0.05 (+2.05%)
Prev Close
$2.44
$2.44
Open
$2.46
$2.46
Day's High
$2.50
$2.50
Day's Low
$2.44
$2.44
Volume
163,568
163,568
Avg. Vol
89,957
89,957
52-wk High
$6.81
$6.81
52-wk Low
$2.06
$2.06
About
Amicus Therapeutics, Inc. (Amicus) is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for treating a range of diseases, including lysosomal storage diseases and diseases of neurodegeneration. It is focused on... (more)
Overall
| Beta: | 1.08 |
| Market Cap (Mil.): | $121.10 |
| Shares Outstanding (Mil.): | 49.63 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| FOLD.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -1.09 | -- | -- |
| ROI: | -56.42 | -2.58 | 18.76 |
| ROE: | -79.20 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
| Shire PLC (SHP.L) | 2,440.00p | +38.00 |
| Shire PLC (3159084.L) | -- | -- |
| Actelion Ltd (ATLN.VX) | CHF61.50 | +0.50 |
| Protalix BioTherapeutics Inc. (PLX.TA) | 1,912.00₪ | -22.00 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

